SY42 - Central Precocious Puberty: Evolving Concepts in Diagnosis, Treatment, and Surveillance

Monday, June 15, 2026

10:30 AM - 12:00 PM CT

Location: Room W185ABC

Symposium Chair(s)

Yee-Ming Chan, MD, PhD (he/him/his)

Attending Physician in Pediatrics
Pediatrics
Boston Children's Hospital
Canton, MA, United States

Disclosure(s): No relevant disclosure to display

Disclosure(s):

Yee-Ming Chan, MD, PhD: No relevant disclosure to display

Ana Claudia Latronico, MD, PhD: No financial relationships to disclose

Erica A. Eugster, MD: No relevant disclosure to display

Liat de Vries, MD: No financial relationships to disclose

Precocious puberty is a concerning condition affecting children worldwide that has been associated with long-term adverse outcomes. The most common form of precocious puberty is the premature reactivation of the hypothalamic GnRH pulsatile secretion, known as central precocious puberty, a common condition in pediatric endocrine care. This session will put in context advances in the approach of central precocious puberty, highlighting recent findings and novelties on etiology, treatment, and long-term surveillance into adulthood.

Presentations:

10:30 AM - 11:00 AM CT

When Puberty Comes Too Soon: Adult Health Impacts and Perspectives of Central Precocious Puberty
Symposium Speaker: Liat de Vries, MD (she/her/hers) – Schneiders' Children Medical Center in Israel
11:00 AM - 11:30 AM CT

Innovations in the Management of Central Precocious Puberty: Evidence and Principles of Current Therapies
Symposium Speaker: Erica A. Eugster, MD – Indiana University Schl of Medical
11:30 AM - 12:00 PM CT

DLK1 Deficiency: The Emerging Role of a Factor Linking Central Precocious Puberty and Metabolic Disturbance
Symposium Speaker: Ana Claudia Latronico, MD, PhD (she/her/hers) – Sao Paulo Medical School, Sao Paulo University